BCMU
ALXN

BlueCrest Capital Management (UK)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,564
Closed -$244K – 669
2014
Q2 		$244K Buy
+1,564
New +$244K 0.01% 463